Page 11 of diabetes

Early metformin use may cut COVID-19 hospitalisation, death risk by half: Study

The study included 1,323 participants most at risk of serious outcomes — adults over 30 and with body mass index…

August 19, 2022 17:52 IST

Eli Lilly, Eli Lilly India, Vineet Gupta, diabetes, cancer, oncology, healthcare news, pharma news,

We are expanding access to our diabetes therapies through strategic partnerships with leading Indian pharma cos: Vineet Gupta, MD, Eli Lilly India

Driving awareness and expanding access to treatment requires collaboration amongst multiple public and private stakeholders, Gupta told Financial Express.com.

August 13, 2022 12:05 IST

LTL-obesity relationship being reported in women for first time, claims study

LTL is at its longest at birth, shortens rapidly until adolescence and then shortens at a reduced rate until old…

August 5, 2022 10:19 IST

Non-communicable diseases, World Health Organization, Heart attacks, diabetes, cancer, health news, NCDs, healthcare news,

Novo Nordisk and Roche partner together to enhance access to care for children with Type 1 diabetes in India

This partnership is part of NNEF’s Changing Diabetes in Children (CDiC) programme which is a public-private partnership that provides “comprehensive…

Updated: August 4, 2022 16:57 IST

World Diabetes Day, World Diabetes Day 2022, Naturepathy, Diabetes cure, diabetes treatment, health news,

Cadila Pharma launches generic versions of sitagliptin for type 2 diabetes in India

Meanwhile, the company has also launched a potent combination of Sitagliptin and Metformin and branded it as Jankey M.

August 2, 2022 11:52 IST

Diabetes, Type 2 diabetes, AI-enabled medical therapy, Twin Health, health news, healthtech news,

How uncontrolled diabetes makes varicose veins worse?

Uncontrolled diabetes can worsen one’s varicose veins: High levels of blood glucose levels will travel via the circulatory system, damage…

July 25, 2022 17:19 IST

Glenmark, Sitagliptin, Type 2 diabetes, health news, phama news,

Glenmark launches Sitagliptin and its fixed-dose combinations at affordable price for Adults with Type 2 Diabetes in India

Moreover, in India, patients have to bear the drug cost on their own and so the price of the drug…

July 7, 2022 13:37 IST

healthcare revolution, health news, pharma news,

HealthPlix achieves 20 million patients mark, consultation with diabetologists top the charts

The company currently serves close to 2.2 per cent of India’s patient population and is working towards national health missions…

July 6, 2022 15:29 IST

ICMR-INDIAB, Diabetes, diabetes in India, dietary changes, health news,

Sanofi slashes price of its insulin product for uninsured US citizen

Last year, the Rand Corporation pointed out that the average list price in Canada was $12 compared to $98.70 in…

June 30, 2022 17:35 IST

Diabetes almost doubles risk of death from COVID-19: Study

The researchers from the University of Aberdeen in the UK reviewed data from hundreds of thousands of people from all…

May 11, 2022 17:34 IST

This latest innovation from Roche Diabetes Care aims to make the process of insulin delivery easier. This can then lead to increase in compliance and improve outcomes for People with Diabetes (PwD).

Roche Diabetes Care launches ACCU-FINE pen needles for better diabetes management

Available in packs of 100 in three variants including a 33G 4mm variant, the ACCU-FINE needles are aimed at increasing…

May 9, 2022 17:38 IST

The programme aims to help people in effective diabetes management so that they can take ownership of their health with external help and expert guidance.

GOQii launches integrated lifestyle medicine programme for Diabetics

Considering the fact that self care along with guidance and holistic lifestyle modification are key for managing diabetes, GOQii has…

May 4, 2022 17:31 IST

Oral semaglutide , Type-2 Diabetes , GLP-1 Receptor Agonist, cardio-metabolic risk factors, Diabetes, Novo Nordisk India

Why Oral Semaglutide is being called a game changer in Type-2 Diabetes management? Its makers explain

Due to its tangible benefits beyond glycaemic control, GLP-1 based treatment is becoming an important armamentarium of Type 2 diabetes…

Updated: March 31, 2022 17:36 IST

Covid-19: Infection increases risk of Type 2 diabetes, two studies find

The higher risk of diabetes was evident in people with mild or asymptomatic Covid-19 and even in people with no…

March 24, 2022 12:49 IST

Diabetic Retinopathy, healthcare, screening, Family Health Centres, FHCs, Thiruvananthapuram district, Kerala, PACS, Remidio

Technological intervention helps guided Diabetic Retinopathy screening take off in Indian healthcare

Remidio’s CE marked and FDA 510k registered retinal imaging devices have helped screen and impact more than 7.5 million patients…

March 1, 2022 13:29 IST

Biocon Biologics, Viatris, Biosimilars, definitive agreement, CCPS, Serum Institute Life Sciences, Kiran Mazumdar Shaw

Biocon Biologics to acquire Viatris’ Biosimilars for up to USD 3.3 billion in stock and cash

The acquisition of biosimilars assets of Viatris significantly strengthens BBL’s position in providing affordable access to patients through its portfolio…

Updated: February 28, 2022 11:31 IST

Related News

US tourist visa: Applicant’s B1/B2 visa approved without hassle, officer says ‘I don’t need to…’

Indian employee in UAE opens up about favouritism and exclusion in small company

‘I sit 9–5 doing nothing’: Indian worker in UAE says he’s ‘invisible’ at job, left out of WhatsApp groups and team culture

Thinking of Retiring in India? NRIs Say Traffic Might Stop You.

US couple returns to India after 25 years, reveals what is driving NRIs away

Bangalore employee shares experience of toxic workplace and overwork at AI software firm

‘I cry every night’: Bengaluru employee shares struggle with toxic workplace, seeks exit amid mental strain

An incorrect name on your Aadhaar can lead to severe issues with KYC (Know Your Customer) compliance, bank accounts, and benefits distribution.

Aadhaar card online update: How to change name, address, date of birth and phone number online in simple steps

Peak XV-backed Yubi raises Rs 411 cr from EvolutionX

Business22 min ago

Yubi Group, backed by Peak XV and TVS Capital, secures ₹411 crore in a new round of funding through a combination of long-term structured debt and equity. EvolutionX Debt Capital commits ₹336 crore, while founder Gaurav Kumar invests ₹75 crore in equity.

View all shorts